Methsolon 1G IV/IM Injection

🔹 Endocrine Disorders

Primary or secondary adrenocortical insufficiency

• Acute adrenal crisis
• Congenital adrenal hyperplasia
• Nonsuppurative thyroiditis
• Cancer-associated hypercalcemia
• Shock unresponsive to standard treatment

🔹 Rheumatic Diseases

• Rheumatoid arthritis, including juvenile forms
• Psoriatic arthritis, gouty arthritis
• Ankylosing spondylitis
• Bursitis, epicondylitis, tenosynovitis

🔹 Collagen Vascular Diseases

• Active flares of systemic lupus erythematosus (SLE)
• Polymyositis, dermatomyositis
• Acute rheumatic carditis

🔹 Skin Conditions

• Severe psoriasis, seborrheic dermatitis, pemphigus
• Exfoliative dermatitis, Stevens-Johnson syndrome
• Bullous dermatitis herpetiformis, mycosis fungoides

🔹 Allergic Reactions

• Bronchial asthma, contact dermatitis, atopic dermatitis
• Drug-induced allergic reactions
• Acute allergic laryngeal edema
• Anaphylactic reactions (supportive therapy)

🔹 Ophthalmic Inflammatory Disorders

• Iritis, chorioretinitis, keratitis
• Optic neuritis, uveitis, allergic conjunctivitis
• Herpes zoster ophthalmicus, corneal ulcers

🔹 Gastrointestinal Conditions

• Ulcerative colitis and Crohn’s disease during severe flares

🔹 Respiratory Diseases

• Sarcoidosis, aspiration pneumonitis
• Pulmonary tuberculosis (in combination with anti-TB therapy)
• Berylliosis, Loeffler’s syndrome

🔹 Hematologic Disorders

• Autoimmune and idiopathic thrombocytopenic purpura
• Hemolytic anemia, erythroblastopenia
• Secondary thrombocytopenia

🔹 Oncology Support

• Adjunct in leukemias and lymphomas in adults
• Acute lymphoblastic leukemia in children

🔹 Edematous States

• Treatment of idiopathic nephrotic syndrome (non-uremic)
• Lupus nephritis with significant proteinuria

🔹 Neurological & Infectious Conditions

• Tuberculous meningitis (with subarachnoid block)
• Trichinosis with neurological or myocardial involvement

⚙️ 

💊 

🧪 Slow tapering is essential after prolonged use to avoid adrenal suppression.